Dr. Bao Sun | Analytical Chemistry | Best Researcher Award

The Second Affiliated Hospital of Xi’an Medical University, China

Profiles

• Scopus Profile

Academic Background

Dr. Bao Sun is currently a full-time Ph.D. candidate at the School of Life Sciences, Northwestern University, a Double First-Class institution. Under the supervision of Professor Zheng Xiaohui, a national talent recognized by the “Hundred Thousand Talents Project,” Dr. Sun is engaged in advanced research in the fields of clinical pharmacology and drug efficacy. He holds a Master’s degree in Pharmacology from Zhengzhou University, also a Double First-Class university, where he studied under Professor Qiao Hailing. His academic journey has been rooted in translational medical research with strong emphasis on drug mechanism and patient-centric therapy.

Professional Experience

Dr. Sun works at the Second Affiliated Hospital of Xi’an Medical College, where he has served in the Department of Pharmacy with primary responsibilities in clinical pharmacy services and pharmaceutical management. He has undergone clinical pharmacist training at Xijing Hospital, earning a Clinical Pharmacist Certificate issued by the Chinese Medical Association Clinical Pharmacist Branch. His experience bridges academic knowledge with hospital-based application, particularly in optimizing therapeutic strategies for patients.

Research Focus and Publications

Dr. Sun’s research interests lie in neuropathic pain mechanisms, anti-inflammatory agents, and drug-resistance modulation. He is a co-author of several high-impact papers:

• “A novel compound DBZ ameliorates neuropathic pain and anxiety-like behaviors in SNI mouse models”, published in Talanta Open (IF = 4.2), explores the PI3K/AKT/Fyn/NMDA signaling pathway.

• “DBZ alleviates chronic inflammatory pain”, published in Drug Resistance (IF = 4.177), underscores the compound’s therapeutic promise.

• “A Rare Case of Biliary Cryptococcosis”, a noteworthy clinical observation contributing to case-based medical literature.

• Contributions to pharmacist-driven treatment models and literature reviews in infection and pharmacological care.

Technical and Professional Skills

Dr. Sun demonstrates robust capabilities in drug efficacy evaluation, clinical trial collaboration, and pharmacological data interpretation. He applies molecular pharmacology techniques and integrates clinical data with biochemical pathways to improve patient outcomes. He is experienced in multidisciplinary research, coordinating between physicians, pharmacists, and researchers for holistic therapeutic interventions.

Leadership and Service

As the Secretary of the Youth Work Committee of the Shaanxi Pharmaceutical Society, Dr. Sun is responsible for event planning, academic coordination, and inter-organizational engagement. He has organized and delivered nine city-level seminars under the “Multidisciplinary Training Seminar on Drug Clinical Application and Management” program, contributing significantly to regional pharmaceutical education.

Awards and Recognition

Dr. Sun was honored as an Outstanding Worker by the Shaanxi Pharmaceutical Association. He also received the Third Prize in the “Medicine” TED Speech Competition organized by the Shaanxi Youth Pharmacist Alliance. His academic and public communication skills have been recognized both in scientific and professional platforms.

Legacy and Future Contributions

With a strong foundation in clinical pharmacology, academic research, and hospital-based pharmacy, Dr. Bao Sun continues to bridge the gap between laboratory research and bedside care. His future goals include contributing to personalized medicine, developing novel analgesics, and enhancing interdisciplinary collaboration in clinical research. His leadership in pharmaceutical education ensures that his influence will extend across both academic and healthcare domains.

Notable Publications

1. A novel compound DBZ ameliorates neuropathic pain and anxiety-like behaviors in SNI mouse model: Role of PI3K/AKT/Fyn/NMDA signal pathway
   Authors: Bao Sun, Le Yang, Saiying Wang, et al.
   Journal: Under Review
   Year: Not yet published

2. A Novel Compound DBZ Alleviates Chronic Inflammatory Pain and Anxiety-Like Behaviors by Targeting the JAK2-STAT3 Signaling Pathway
   Authors: Bao Sun, M. Wu, Y. Ru, et al.
   Journal: Journal of Biological Chemistry
   Year: 2025 (May 9)

3. Development of a non-derivatized LC-MS/MS method for simultaneous quantification of ten neurotransmitters in five neuroinflammatory mouse models
   Authors: Bao Sun, Zhaodi Xia, Chen Wang, et al.
   Journal: Talanta Open
   Year: 2025

4. A Rare Case of Biliary Cryptococcosis: Clinical Pharmacist Participation in Treatment and Pharmaceutical Care and Literature Review
   Authors: Bao Sun, Yingshuang Tang, Dan Chen, et al.
   Journal: Infection and Drug Resistance
   Year: 2023

5. Hepatoprotective Role of Berberine on Doxorubicin-Induced Hepatotoxicity – Involvement of Cyp
   Authors: Bao Sun, Yue Yang, Mengzi He, et al.
   Journal: Current Drug Metabolism
   Year: 2020